ArticleJournal of experimental & clinical cancer research : CR2026
Mesenchymal stem cell-induced metabolic reprogramming of EGFR-wild-type tumor cells drives therapeutic resistance in EGFR-mutant non-small cell lung cancer.
Hongyu Bie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.